原发性高血压夜间血压水平与左心室重塑脂联素及高敏C反应蛋白的关系
被引量:3
摘要
原发性高血压(EH)患者存在血管壁炎症反应,炎症反应参加了高血压的发生发展。左心室肥厚是高血压左心室重塑重要的病理变化。脂联素具有抗炎及抗动脉硬化作用。C反应蛋白(CRP)是参与动脉粥样硬化形成的重要炎性因子。
参考文献3
-
1Blake GJ,Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res, 2001,89: 763-771.
-
2Imatoh T, Miyazaki M, Momose Y, et al. Adiponectin levels associated with the development of hypertention:aprospective study. Hypertetm Res, 2008,31 : 229-233.
-
3李小平,杨成悌,张灵,常鹏.高血压病患者血清脂联素水平的研究[J].中华心血管病杂志,2004,32(7):596-599. 被引量:37
二级参考文献15
-
1Scherer PE, Willians S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995,270: 26746-26749.
-
2Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo), 1996, 120: 803-812.
-
3Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999, 257: 79-83.
-
4Hanley AJ, Connelly PW, Harris SB, et al. Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care, 2003, 26: 3219-3225.
-
5Dzielinska Z, Januszewicz A, Wiecek A, et al. Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease. Thromb Res, 2003, 110: 365-369.
-
6Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-KDa adipocyte complement -related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Nat Acad Sci USA,2001,98:2005-2010.
-
7Tomas E, Tsao TS, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acety1-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA, 2002, 99 : 16309-16313.
-
8Yamauchi T, Kamon J, Mizokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 2002, 8: 1288-1295.
-
9Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100: 2473-2476.
-
10Ouchi N, Kihara S, Arita Y, et al. Adipocyte -derived plasma protein, adiponectin suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001, 103 : 1057-1063.
共引文献36
-
1韦秀英,龙入虹,李柳杭.2型糖尿病合并高血压患者血浆脂联素的变化[J].中国老年学杂志,2005,25(7):745-746. 被引量:1
-
2梁晓萍,韩全水,文锦丽,林小兰,杨夏敏,李岚.超重和肥胖人群血清脂联素水平变化与高血压病的关系[J].中国医师杂志,2005,7(11):1468-1469. 被引量:2
-
3梁晓萍,韩全水,文锦丽,林小兰,杨夏敏,李岚.超重和肥胖人群高血压病的患病率及血清脂联素水平的变化[J].中华心血管病杂志,2006,34(1):41-43. 被引量:10
-
4王国平,曹荣辉,吕吉元,常宜林,张建军,陈树兰.白藜芦醇对慢性心力衰竭患者脂联素及细胞因子的影响[J].中国循环杂志,2006,21(3):182-185. 被引量:3
-
5刘美霞,高铁三,康文巧,李如意.老年高血压病患者血清脂联素水平的检测[J].河北医药,2006,28(9):825-826. 被引量:3
-
6李丙蓉,郑丹,邓华聪,刘金波,兰丽珍,郑宏庭.人脂联素重组腺病毒对内皮细胞增殖和一氧化氮合酶的影响[J].中华心血管病杂志,2006,34(12):1122-1125. 被引量:6
-
7李冰,王建.辛伐他汀对不稳定性心绞痛患者脂联素和超敏C反应蛋白水平的影响[J].医学临床研究,2007,24(3):441-442. 被引量:7
-
8杜春辉,李海涛.脂联素与高血压关系的研究进展[J].中国煤炭工业医学杂志,2007,10(5):511-512. 被引量:2
-
9胡明磊,胡世红.血浆脂联素水平与原发性高血压的关系[J].中国组织工程研究与临床康复,2007,11(21):4213-4216. 被引量:2
-
10李华,徐云云,杨秋萍.高血压与代谢综合征[J].云南医药,2007,28(3):308-312. 被引量:2
同被引文献23
-
1Kumar R, Nejatizadeh A, Gupta M,et al. The epistasis between vascular homeostasis genes is apparent in essential hypertension. Atherosclerosis, 2012,220(2) :418-424.
-
2中国高血压防治指南修订委员会.中国高血压防治指南(2005年).高血压杂志,2005,13(1):40-42..
-
3Sengul C, Cevik C, Ozveren O, et al. Telmisartan decreases atrial electremechanical delay in patients with newly diagnosed essential hypertension. J Electrocardiol, 2012,45(2) : 123-128.
-
4Ronconi V, Turchi F, Rilli S, et al. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. Nutr Metab Cardiovasc Dis, 2010,20 (2):93-100.
-
5Yoshida H, Yanai H, Ito K,et al. Administration of natural astaxanthin increases serum HDL-chdesterol and adiponectin in subjects with mild hyperlipidemia. Athemsclemsis, 2010,209 (2) : 520-523.
-
6Alioglu E, Turk U, Cam S, et al. Polymorphisms of the methylenetetrahydrofolate reductasc, vascular endothelial growth factor, endothelial nitric oxide synthase, monoeytc chemoattractant protein-1 and apolipoprotein E genesare not associated with carotid intima-media thickness. Can J Cardiol, 2009,25 ( 1 ) : 1-5.
-
7Eklund C, Friberg P, Gan LM. High-resolution radial artery intima-media thickness and cardiovascular risk factors in patients with suspected coronary artery dlsease---comparison with common carotid artery intima-mediathickness.-Atherosclerosis, 2012,221 (1):118-123.
-
8van Berendoncks AM, Beckers P, Hoymans VY,et al. 13 -blockers modify the prognostic value of adiponectin in chronic heart failure. IntJ Cardiol, 2011,150(3) :296-300.
-
9Nakanishi-Minami T, Kishida K, Nakagawa Y, et al. Carotid intima-media thickness, but not visceral fat area or adiponectin, correlates with intracoronary stenosis detected by muhislice computed tomography in people with type 2 diabetes and hypertension. Diabetes Res Clin Pract, 2012,95( 1 ) :23-26.
-
10Hernesniemi J A,Karhunen P J ,Oksala N,et al. Interleukin 18gene promoter polymorphism ; a link between hypertension andpre-hospital sudden cardiac death: the Helsinki Sudden DeathStudy[J]. Eur Heart J,2009,30(23) :2939-2946.
引证文献3
-
1陆洋,钱纪银,陈爱芳.原发性高血压患者血清脂联素水平的变化及其与颈动脉内膜中层厚度的关系[J].中国医师进修杂志,2012,35(36):16-19. 被引量:2
-
2侯文华,韩玲,刘克宇,苗永国,陈洪涛.原发性高血压左心室肥厚患者脂蛋白磷脂酶A2及脂联素检测的临床意义[J].南昌大学学报(医学版),2014,54(10):15-17. 被引量:2
-
3侯文华.原发性高血压左心室肥厚患者Hcy、BNP及hs-CRP测定的临床意义[J].南昌大学学报(医学版),2014,54(11):33-35. 被引量:5
二级引证文献9
-
1罗雪清,梁燕玲,黄显南,陈成彩,李静.原发性高血压患者心脏及颈动脉超声改变与血清hs-CRP、Hcy、CysC水平的相关性研究[J].广西医科大学学报,2015,32(3):443-446. 被引量:13
-
2杨萍,孙书明,殷国田.替米沙坦对原发性高血压患者血清脂联素和颈动脉粥样硬化的影响[J].临床心血管病杂志,2015,31(11):1192-1194. 被引量:10
-
3刁杰,夏豪.原发性高血压病人同型半胱氨酸水平与动脉病变及左心室肥厚的关系探讨[J].中西医结合心脑血管病杂志,2016,14(11):1197-1200. 被引量:16
-
4代西艳,于斌.血清Hcy、hs-CRP检测在H型高血压冠心病患者中的意义[J].中国当代医药,2017,24(4):48-51. 被引量:12
-
5唐玉宏.原发性高血压患者血浆hsCRP、Hcy水平与血压变异性的相关性[J].心血管康复医学杂志,2018,27(1):5-9. 被引量:1
-
6舒海洲,王莉,赵良平,陈聿奇,王茂松,徐卫亭,陈建昌.血清脂联素水平对急性心肌梗死发病及预后的影响研究[J].中国医师进修杂志,2018,41(6):536-540. 被引量:4
-
7高淑华,罗晋武.H型高血压与冠心病及冠状动脉病变程度的关系探讨[J].中西医结合心脑血管病杂志,2019,17(6):913-914. 被引量:14
-
8王叶宝,李建民.高血压患者血清脂联素、炎症因子与左室肥厚的相关性分析[J].现代诊断与治疗,2020,31(3):343-345. 被引量:2
-
9王杏芬,高永红,孙萌.高血压病患者APN、MMP-9、AngⅡ、ET-1水平与左心室肥厚的相关性研究[J].河北医药,2021,43(7):1037-1039. 被引量:7
-
1吕萍,李自成,孙蓓,常青.C反应蛋白与高血压病关系探讨[J].广东医学,2003,24(3):256-257. 被引量:19
-
2张治平,林笋镁.麝香保心丸联合西药治疗顽固型心绞痛临床研究[J].新中医,2016,48(5):40-42. 被引量:1
-
3周骞,段吾磊,唐路军,陆朵梅,陈橙,莫莉,谭元生.TNF-α与原发性高血压的相关性及中医药干预研究进展[J].中国循证心血管医学杂志,2017,9(2):240-242. 被引量:22
-
4金娇杨,王俊.阿托伐他汀强化降脂对2型糖尿病患者血脂和心血管并发症的影响[J].中国药物与临床,2015,15(5):674-675. 被引量:6
-
5王玉倩,葛久欣,吴爱丽,姜春艳,刘雨晶.瑞舒伐他汀治疗高血压骨质疏松症患者的研究[J].黑龙江医学,2013,37(4):271-272.
-
6孙丽霞.低分子肝素联合阿托伐他汀钙治疗合并糖尿病的不稳定性心绞痛疗效观察[J].现代医药卫生,2010,26(5):742-743. 被引量:2
-
7闫胜敏,李拥军.原发性高血压与脂联素、C反应蛋白关系及机制的研究进展[J].临床合理用药杂志,2011,4(7):145-146. 被引量:5
-
8任忠法,薛现中,官庆波.2型糖尿病患者抗动脉粥样硬化的临床研究进展[J].医学综述,2009,15(11):1696-1698. 被引量:5
-
9杨阳,李平.三七粉对原发性高血压病患者的疗效观察[J].中医临床研究,2017,9(3):29-30. 被引量:8
-
10彭定凤,唐哨勇,胡勇钧.普伐他汀对血脂正常高血压患者血压及高敏C反应蛋白水平的影响[J].吉林大学学报(医学版),2012,38(5):1042-1042. 被引量:6